Her2/Neu (HER2) Intratumoral Genetic Heterogeneity in Breast Cancer and Its Concurrent Axillary Metastases

被引：0
|
作者：
Astvatsaturyan, K. [1 ]
Bose, S. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
LABORATORY INVESTIGATION | 2013年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
107
引用
收藏
页码：28A / 28A
页数：1
相关论文
共 50 条
  • [41] Reply to 'Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance'
    Lee, Hee Jin
    Park, So Yeon
    MODERN PATHOLOGY, 2013, 26 (04) : 610 - 611
  • [42] Chromosome 17 polysomy is common in breast cancer metastases and does not correlate with HER2/neu amplification or HER2/neu 2+staining by immunohistochemistry
    Varghese, L.
    Vanderwerf, S.
    Sweeney, C.
    Blair, C.
    Forster, C.
    Gulbahce, E.
    MODERN PATHOLOGY, 2007, 20 : 52A - 53A
  • [43] HER2:: The Neu prognostic marker for breast cancer
    Tsongalis, GJ
    Ricci, A
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2001, 38 (02) : 167 - 182
  • [44] HER2/neu as a predictive factor in breast cancer
    Piccart, M
    Hamilton, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S84 - S84
  • [45] HER2 intratumoral genetic and non-genetic heterogeneity in metastatic colorectal cancer
    Sawada, K.
    Nitta, H.
    Nakamura, Y.
    Okamoto, W.
    Taniguchi, H.
    Komatsu, Y.
    Hara, H.
    Kato, T.
    Nishina, T.
    Ohta, T.
    Esaki, T.
    Yoshino, T.
    Fujii, S.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1319 - S1320
  • [46] Clinical significance of intratumoral HER2 heterogeneity in gastric cancer
    Lee, Hee Eun
    Park, Kyoung Un
    Yoo, Seol Bong
    Nam, Soo Kyung
    Park, Do Joong
    Kim, Hyung-Ho
    Lee, Hye Seung
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (06) : 1448 - 1457
  • [47] Intratumoral heterogeneity of HER2 protein and amplification of HER2 gene in salivary duct carcinoma
    Kondo, Yusuke
    Kikuchi, Tomoki
    Esteban, Joaquim Carreras
    Kumaki, Nobue
    Ogura, Go
    Inomoto, Chie
    Hirabayashi, Kenichi
    Kajiwara, Hiroshi
    Sakai, Akihiro
    Sugimoto, Ryousuke
    Otsuru, Mitsunobu
    Okami, Kenji
    Tsukinoki, Keiichi
    Nakamura, Naoya
    PATHOLOGY INTERNATIONAL, 2014, 64 (09) : 453 - 459
  • [48] Serum HER2/neu levels in breast cancer patients with different level of tumor HER2/neu protein expression
    Kushlinsky, Nicolai
    Gershtein, Elena
    Shyroky, Vyacheslav
    Ermilova, Valeriya
    Tchemeris, Galina
    Letyagin, Victor
    TUMOR BIOLOGY, 2007, 28 : 95 - 95
  • [49] Early results of combined Her-2/neu (HER2) immunotherapy using a HER2 peptide vaccine with concurrent trastuzumab for metastatic breast cancer.
    Webster, D.
    Waisman, J.
    MacLeod, B.
    dela Rosa, C.
    Higgins, D.
    Fintak, P.
    Childs, J.
    Slota, M.
    Salazar, L.
    Disis, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S79 - S80
  • [50] Non-genetic HER2 intratumoral heterogeneity with newly discovered HER2 positive tumour cells in gastric cancer: HER2 mRNA expression in amplified HER2 gene tumour cells without HER2 protein over-expression
    Nitta, H.
    Kaito, A.
    Lo, A.
    Murillo, A.
    Munroe, D.
    Ochiai, A.
    Kuwata, T.
    VIRCHOWS ARCHIV, 2020, 477 : S192 - S192
12345